ArticleClinical & experimental ophthalmology2026
Lessons Learnt From 25 Years of Endophthalmitis: Causes, Microbiology and Visual Outcome Trends.
Article in Clinical & experimental ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Endophthalmitis Paradigm Shift: Lessons From 25 Years of Changing Ophthalmic Practice.Clinical & experimental ophthalmology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWe aimed to study the trends in microbiology, precipitating causes and outcomes of endophthalmitis in Victoria, Australia, over a 25-year period. To the best of our knowledge, this is the longest study of endophthalmitis in Australia.
methodsWe conducted a prospective study of all endophthalmitis cases to the Royal Victorian Eye and Ear Hospital, a state-wide tertiary referral centre for ocular conditions, thereby capturing nearly all state-wide endophthalmitis cases. All patients presenting with endophthalmitis were included. Demographic data, examination findings, microbiology, management and outcomes were collected.
resultsA total of 1423 eyes from 1408 patients were included. The mean (SD) age was 71.35 (16.12). The median presenting best-corrected visual acuity was hand movements. Cataract surgery formed the plurality of annual cases until 2009; intravitreal injections exceeded following. The rate of endophthalmitis secondary to cataract surgery decreased from 0.29%-0.02% over the 25-year period, with a significant decrease following the introduction of prophylactic cefazolin; however, the rate of endophthalmitis secondary to intravitreal injections remained relatively stable (0.01%-0.04%). 63.03% were culture-positive; the plurality grew gram-positive bacteria (42.94%). Visual outcomes were biphasic; 44.99% had a final BCVA of less than 6/60 (including enucleation/evisceration), while 30.6% reached 6/12 or better. Poor visual outcomes were associated with corneal infection; cataract surgery and intravitreal injections were associated with better outcomes.
conclusionsThis study demonstrated declining rates of endophthalmitis secondary to cataract surgery and stable rates of endophthalmitis secondary to intravitreal injections. Visual outcomes were bimodal; while many do very poorly, some have good visual recovery.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.